Your browser doesn't support javascript.
loading
Spironolactone use is associated with improved outcomes in heart failure with mid-range ejection fraction.
Enzan, Nobuyuki; Matsushima, Shouji; Ide, Tomomi; Kaku, Hidetaka; Higo, Taiki; Tsuchihashi-Makaya, Miyuki; Tsutsui, Hiroyuki.
Afiliação
  • Enzan N; Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Matsushima S; Department of Cardiovascular Medicine, Kyushu University Hospital, Maidashi 3-1-1, Higashi-ku, Fukuoka, 812-8582, Japan.
  • Ide T; Department of Experimental and Clinical Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Kaku H; Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Higo T; Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Tsuchihashi-Makaya M; Kitasato University School of Nursing, Sagamihara, Japan.
  • Tsutsui H; Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
ESC Heart Fail ; 7(1): 339-347, 2020 02.
Article em En | MEDLINE | ID: mdl-31951680
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Espironolactona / Volume Sistólico / Sistema de Registros / Função Ventricular Esquerda / Insuficiência Cardíaca Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Espironolactona / Volume Sistólico / Sistema de Registros / Função Ventricular Esquerda / Insuficiência Cardíaca Idioma: En Ano de publicação: 2020 Tipo de documento: Article